Commonwealth Financial Services’s AstraZeneca AZN Stock Holding History

Commonwealth Financial Services’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$18K	Buy	288 +76	+36%	+$4.42K	0.02%	156
2016 Q4	$11K	Sell	212 -172	-45%	-$9.77K	0.01%	171
2016 Q3	$25K	Buy	384 +115	+43%	+$7.52K	0.02%	113
2016 Q2	$16K	Hold	269	–	–	0.02%	144
2016 Q1	$15K	Hold	269	–	–	0.02%	131
2015 Q4	$18K	Hold	269	–	–	0.06%	119
2015 Q3	$17K	Hold	269	–	–	0.02%	126
2015 Q2	$17K	Hold	269	–	–	0.02%	143
2015 Q1	$18K	Sell	269 -933	-78%	-$64.8K	0.02%	145
2014 Q4	$85K	Buy	+1,202	New	+$86.1K	0.08%	74

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Commonwealth Financial Services's AZN Position: Q1 2017 in Review

Commonwealth Financial Services increased its AstraZeneca (AZN) stake by 36% in Q1 2017, buying an estimated $4.42K and bringing the position to 288 shares worth $18K. The position accounts for 0.02% of the portfolio, ranked #156.

Commonwealth Financial Services first reported a position in AZN in Q4 2014 and has held it in 10 quarters since. The position peaked at $85K in Q4 2014. 461 funds tracked by Wall St. Rank hold AZN as of Q1 2017.

Commonwealth Financial Services held 288 shares of AstraZeneca worth $18K as of Q1 2017.
Commonwealth Financial Services bought 76 AstraZeneca shares in Q1 2017, an estimated $4.42K.
AstraZeneca made up 0.02% of Commonwealth Financial Services's portfolio in Q1 2017, its #156 holding.
Commonwealth Financial Services first reported a position in AstraZeneca in Q4 2014 and has held it in 10 quarters since.
Commonwealth Financial Services's AstraZeneca position peaked at $85K in Q4 2014.
461 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2017.

Based on Commonwealth Financial Services's 13F filing for Q1 2017, filed 20 Apr 2017.